Abeona Therapeutics (ABEO) Return on Sales: 2011-2025
Historic Return on Sales for Abeona Therapeutics (ABEO) over the last 13 years, with Sep 2025 value amounting to -60.44%.
- Abeona Therapeutics' Return on Sales rose 6329.00% to -60.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -60.44%, marking a year-over-year increase of 6329.00%. This contributed to the annual value of -13.59% for FY2023, which is 2294.00% up from last year.
- Per Abeona Therapeutics' latest filing, its Return on Sales stood at -60.44% for Q3 2025, which was up 44.63% from -109.16% recorded in Q2 2025.
- Abeona Therapeutics' Return on Sales' 5-year high stood at 105.00% during Q3 2021, with a 5-year trough of -218.58% in Q1 2025.
- Its 3-year average for Return on Sales is -65.37%, with a median of -47.46% in 2023.
- In the last 5 years, Abeona Therapeutics' Return on Sales skyrocketed by 13,446bps in 2023 and then slumped by 20,734bps in 2025.
- Quarterly analysis of 5 years shows Abeona Therapeutics' Return on Sales stood at 25.64% in 2021, then slumped by 6,448bps to -38.84% in 2022, then surged by 2,911bps to -9.73% in 2023, then tumbled by 11,277bps to -123.73% in 2024, then skyrocketed by 6,329bps to -60.44% in 2025.
- Its Return on Sales stands at -60.44% for Q3 2025, versus -109.16% for Q2 2025 and -218.58% for Q1 2025.